| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $202.7M | +40.8% |
| Cost of Revenue | $98.2M | +58.6% |
| Gross Profit | $104.5M | +27.3% |
| R&D Expense | $106.9M | +9.5% |
| SG&A Expense | $102.2M | +21.7% |
| Operating Income | -$115.2M | -7.5% |
| Pre-tax Income | -$93.1M | -15.8% |
| Income Tax | $486K | +219.7% |
| Net Income | -$93.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $38.2M | +74.8% |
| Inventory | $76.7M | +17.1% |
| Current Assets | $544.1M | -12.7% |
| Total Assets | $885.0M | -7.0% |
| Current Liabilities | $108.4M | -10.7% |
| Total Liabilities | $185.2M | -24.0% |
| Stockholders' Equity | $699.7M | -1.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $23.2M | +187.9% |
| Capital Expenditures | $36.2M | +304.9% |
| Investing Cash Flow | $64.8M | +276.6% |
| Financing Cash Flow | -$91.3M | -2732.2% |
| Free Cash Flow | -$13.0M | -1365.4% |
| -16.2% |
| EPS (Basic) | -$4.05 | -11.6% |
| EPS (Diluted) | -$4.05 | -11.6% |